Here are five insights:
1. A total of 965 IBD patients — 61.9 percent suffered from Crohn’s disease and 38.1 percent from ulcerative colitis — formed the study population
2. Researchers included IBD patients with up to five-year follow-up from a longitudinal IBD natural history registry in the study.
2. Among the 965 IBD patients, 29.9 percent had low mean vitamin D levels.
3. Over the five-year study period, subjects with low mean vitamin D required significantly more steroids, biologics, narcotics, computed tomography scans, emergency department visits, hospital admissions and surgery compared with patients who had normal mean vitamin D levels.
4. Subjects with low vitamin D levels had worse pain, disease activity scores and quality of life.
5. Patients who received vitamin D supplements had a significant reduction in their healthcare utilization rates.
More articles on GI/endoscopy:
Crohn’s & Colitis Foundation of American honors Dr. Paul Lebovitz: 5 key notes
GI physician leader to know: Dr. Max Shapiro of Metro Atlanta Gastroenterology
Exalenz Bioscience collaborates with Acute Liver Failure Study Group, EndoChoice CFO buys 5k shares & more – 4 GI company key notes
